Nils Erik
Gilhus
Head of Department
Visit Address:
Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 55 97 50 74
+47 55 97 50 44
E-mail:
Books
- 2012. European Handbook of Neurological Management, Volume 2. Wiley-Blackwell. 353 pages. ISBN: 978-1-4051-8534-9.
- 2011. Intravenous immunoglobulin in the treatment of neurological diseases. Wiley-Blackwell. 16 pages. ISBN: 978-1-4051-8534-9.
- 2011. European Handbook of Neurological Management. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-8533-2.
- 2011. European Handbook of Neurological Management Volume 1. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-5738-4.
- 2011. European Handbook of Neurological Management. Volume 2. Wiley-Blackwell. 353 pages. ISBN: 978-1-4051-8534-9.
- 2011. Screening for tumours in paraneoplastic syndromes. Wiley-Blackwell. 13 pages. ISBN: 978-14051-8534-9.
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 623 pages. ISBN: 1-4051-3050-4.
Journal articles
- 2014. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica. 129: 26-31. doi: 10.1111/ane.12233
- 2014. Total drug treatment and comorbidity in myasthenia gravis: A population-based cohort study. European Journal of Neurology. 21: 948-955. doi: 10.1111/ene.12439
- 2014. EFNS/ENS Guidelines for the treatment of ocular myasthenia. European Journal of Neurology. 21: 687-693. doi: 10.1111/ene.12359
- 2014. Neurological disorders in the Global Burden of Disease 2010 study. Acta Neurologica Scandinavica, Supplementum. 129: 1-6. doi: 10.1111/ane.12229
- 2014. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. Journal of Neurology. 261: 579-588. doi: 10.1007/s00415-013-7239-x
- 2013. The Norwegian Brain Council ('Hjerneradet') united efforts are necessary! Acta Neurologica Scandinavica. 127: 1-4. doi: 10.1111/ane.12042
- 2013. Psychiatric comorbidity and social aspects in pregnant women with epilepsy - The Norwegian Mother and Child Cohort Study. Epilepsy & Behavior. 29: 379-385. doi: 10.1016/j.yebeh.2013.08.016
- 2013. Exposure to antiepileptic drugs in utero and child development - a prospective population-based study. Epilepsia. 54: 1462-1472. doi: 10.1111/epi.12226
- 2013. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding a prospective cohort study on children of women with epilepsy. JAMA Neurology. 70: 1367-1374. doi: 10.1001/jamaneurol.2013.4290
- 2012. Pregnancy complications in patients with epilepsy. Current Opinion in Obstetrics and Gynecology. 24: 78-83. doi: 10.1097/GCO.0b013e32834feb6a
- 2012. Advances in the treatment of myasthenia gravis. Future Neurology. 7: 701-708. doi: 10.2217/fnl.12.73
- 2012. Myasthenia and the neuromuscular junction. Current Opinion in Neurology. 25: 523-529. doi: 10.1097/WCO.0b013e3283572588
- 2012. Traumatiske ryggmargsskader – forekomst, skademekanismer og forløp. Tidsskrift for Den norske legeforening. 132: 831-837. Published 2012-04-17. doi: 10.4045/tidsskr.10.0859
- 2012. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. Journal of Clinical Immunology. 32: 230-237. doi: 10.1007/s10875-011-9617-4
- 2012. Geographical distribution of A seropositive myasthenia gravis population. Muscle and Nerve. 45: 815-819. doi: 10.1002/mus.23271
- 2012. Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. PLoS ONE. 7. 8 pages. doi: 10.1371/journal.pone.0036603
- 2012. Serum levels of matrix metalloproteinases: Implications in clinical neurology. European Neurology. 67: 121-128. doi: 10.1159/000334862
- 2012. Anti voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. Journal of Neurology. 259: 1312-1316. doi: 10.1007/s00415-011-6344-y
- 2012. The Open Facilities for Training in European Neurology (OFTEN): an emerging pan-European exchange programme for junior neurologists. European Journal of Neurology. 19: e54-e55. doi: 10.1111/j.1468-1331.2012.03694.x
- 2011. Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. Muscle and Nerve. 43: 574-577. doi: 10.1002/mus.21919
- 2011. Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG: an International Journal of Obstetrics and Gynaecology. 118: 956-965. doi: 10.1111/j.1471-0528.2011.03004.x
- 2011. Comment from the EFNS scientific committee on the EFNS guideline on the treatment of tension-type headache. European Journal of Neurology. 18: e83-e84. doi: 10.1111/j.1468-1331.2011.03382.x
- 2011. Revised EFNS guidelines for diagnosis and management of post-polio syndrome. Journal of Rehabilitation Medicine. 12.
- 2011. Faglige krav til legespesialister. Overlegen. 4: 20-21.
- 2011. Lambert-Eaton myasthenic syndrome (LEMS); pathogenetic knowledge improves therapy. Autoimmune Diseases. 10. 5 pages. doi: 10.4061/2011/973808
- 2011. NEUROMUSCULAR DISEASE Acute treatment for myasthenia gravis. Nature Reviews Neurology. 7: 132-134. doi: 10.1038/nrneurol.2011.14
- 2011. Myasthenia gravis; a review of available treatment approaches. Autoimmune Diseases. 10. 8 pages. doi: 10.4061/2011/847393
- 2011. Myasthenia gravis autoantibodies have a target also outside the neuromuscular junction. Advances in Clinical Neuroscience & Rehabilitation. 11: 14-15.
- 2011. Partnership and cooperation is necessary to improve and expand neurology. Acta Neurologica Scandinavica. 124: 1-4. doi: 10.1111/j.1600-0404.2011.01541.x
- 2011. Matrix Metalloproteinases in Myasthenia Gravis. European Neurology. 65: 53-58. doi: 10.1159/000322737
- 2011. Arthrogryposis multiplexa congenita; an epidemiologic study of nearly 9 million births in 24 Eurocat registers. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 159: 347-350. doi: 10.1016/j.ejogrb.2011.09.027
- 2011. Treatment for postpolio syndrome. Cochrane Database of Systematic Reviews. 2. 92 pages. doi: 10.1002/14651858.CD007818.pub2
- 2011. Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls. Autoimmune Diseases. 10. 4 pages. doi: 10.4061/2011/151258
- 2011. Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Research. 94: 53-60. doi: 10.1016/j.eplepsyres.2011.01.006
- 2011. PSYCHIATRIC DISEASE AND SOCIAL CHARACTERISTICS IN WOMEN WITH EPILEPSY. THE MoBa DATABASE. European Journal of Neurology. 18: 182-182.
- 2011. Heat-Shock Proteins in Clinical Neurology. European Neurology. 66: 65-69. doi: 10.1159/000329373
- 2011. Emerging scientific opportunities for junior neurologists in the European Federation of Neurological Societies. European Journal of Neurology. 18: E131-E133. doi: 10.1111/j.1468-1331.2011.03398.x
- 2011. Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. European Journal of Neurology. 18: 19-E3. doi: 10.1111/j.1468-1331.2010.03220.x
- 2011. Follow-Up MR Imaging of the Alar and Transverse Ligaments after Whiplash Injury: A Prospective Controlled Study. American Journal of Neuroradiology. 32: 1836-1841. doi: 10.3174/ajnr.A2636
- 2011. Magnetic resonance imaging of the alar and transverse ligaments in acute whiplash-associated disorders 1 and 2 A cross-sectional controlled study. Spine. 36: E434-E440. doi: 10.1097/BRS.0b013e3181da21a9
- 2010. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 17: 1445-1450. doi: 10.1111/j.1468-1331.2010.03089.x
- 2010. Delivery outcome of women with epilepsy:a population-based cohort study. BJOG: an International Journal of Obstetrics and Gynaecology. 117: 1537-1543. doi: 10.1111/j.1471-0528.2010.02694.x
- 2010. Maternal epilepsy and adverse pregnancy outcomes. Expert Review of Obstetrics & Gynecology. 5: 347-355. doi: 10.1586/eog.10.19
- 2010. Myasthenia gravis (MG) in the elderly and MG with anti-ryanodine receptor (RyR) antibodies. European Journal of Neurology. 17: 628-628.
- 2010. Publishing affects funding in neurology. European Journal of Neurology. 17: 147-151. doi: 10.1111/j.1468-1331.2009.02768.x
- 2010. A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway. Spinal Cord. 48: 313-318. doi: 10.1038/sc.2009.133
- 2010. Traumatic spinal cord injury and concomitant brain injury: a cohort study. Acta Neurologica Scandinavica. 122: 51-57. doi: 10.1111/j.1600-0404.2010.01376.x
- 2010. Traumatic spinal cord injury and concomitant brain injury: a 50-year cohort study. European Journal of Neurology. 17: 66-66.
- 2010. Mortality after traumatic spinal cord injury: 50 years of follow-up. Journal of Neurology, Neurosurgery and Psychiatry. 81: 368-373. doi: 10.1136/jnnp.2009.178798
- 2010. Anti-heat shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barre syndrome. Journal of Neuroimmunology. 225: 180-183. doi: 10.1016/j.jneuroim.2010.04.024
- 2010. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 290: 66-69. doi: 10.1016/j.jns.2009.11.006
- 2010. Neurofilament ELISA validation. JIM - Journal of Immunological Methods. 352: 23-31. doi: 10.1016/j.jim.2009.09.014
- 2010. Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 17: 893-902. doi: 10.1111/j.1468-1331.2010.03019.x
- 2010. Cost of disorders of the brain in Norway. Acta Neurologica Scandinavica. 122: 1-5. doi: 10.1111/j.1600-0404.2010.01367.x
- 2010. Clinical aspects of myasthenia explained. Autoimmunity. 43: 344-352. doi: 10.3109/08916931003602130
- 2010. MRI of the transverse and alar ligaments in rheumatoid arthritis: feasibility and relations to atlantoaxial subluxation and disease activity. Neuroradiology. 52: 215-223. doi: 10.1007/s00234-009-0650-4
- 2010. Are MRI high-signal changes of alar and transverse ligaments in acute whiplash injury related to outcome? BMC Musculoskeletal Disorders. 11. doi: 10.1186/1471-2474-11-260
- 2010. Sats på hjerneforskning. Adresseavisen. 43-43. Published 2010-11-18.
- 2009. Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 210: 63-66. doi: 10.1016/j.jneuroim.2009.02.009
- 2009. Interleukin-10 promoter polymorphisms in myasthenia gravis. European Journal of Neurology. 16: 49-49.
- 2009. Myasthenia gravis requiring drug treatment in a national population cohort. European Journal of Neurology. 16: S207. doi: 10.1111/j.1468-1331.2009.02821.x
- 2009. Characteristics of generalised epileptiform activity. Clinical Neurophysiology. 120: 3-10. doi: 10.1016/j.clinph.2008.10.149
- 2009. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG: an International Journal of Obstetrics and Gynaecology. 116: 1736-1742. doi: 10.1111/j.1471-0528.2009.02354.x
- 2009. Autoimmune myasthenia gravis. Expert Review of Neurotherapeutics. 9: 351-358. doi: 10.1586/14737175.9.3.351
- 2009. Is it safe to use statins in patients with myasthenia gravis? Nature Clinical Practice Neurology. 5: 8-9. doi: 10.1038/ncpneuro0988
- 2009. Guidelines, research and improved neurological quality. European Journal of Neurology. 16: 885-886. doi: 10.1111/j.1468-1331.2009.02632.x
- 2009. Poliomyelitis: beyond the year 2000. Journal of the Neurological Sciences. 285: S6-S6.
- 2009. Diagnostic coding accuracy for traumatic spinal cord injuries. Spinal Cord. 47: 367-371. doi: 10.1038/sc.2008.118
- 2009. Geographical distribution of the Norwegian seropositive myasthenia gravis population. European Journal of Neurology. 16: 221-221.
- 2009. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology. 73: 150-151. doi: 10.1212/WNL.0b013e3181ad53c2
- 2009. Resultatbasert finansiering av medisinsk forskning. Tidsskrift for Den norske legeforening. 7. 638-641. doi: doi:10.4045/tidsskr.08.0362
- 2009. Norwegian neurology: present status and future trends. Acta Neurologica Scandinavica. 120: 5-7. doi: 10.1111/j.1600-0404.2009.01202.x
- 2009. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 50: 2130-2139. doi: 10.1111/j.1528-1167.2009.02147.x
- 2009. Health and development in children born to mothers with epilepsy. European Journal of Neurology. 16: 46-46.
- 2009. MRI of the alar and transverse ligaments in whiplash-associated disorders (WAD) grades 1–2: high-signal changes by age, gender, event and time since trauma. Neuroradiology. 51: 227-235. doi: 10.1007/s00234-008-0482-7
- 2008. Titin and ryanodine receptor antibodies and neurmuscular involvement in myasthenia gravis. Future Neurology. 3: 87-92.
- 2008. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. Journal of Neurology. 255: 623-627. doi: 10.1007/s00415-008-0757-2
- 2008. Hjernen vår er fantastisk. Tidsskrift for Den norske legeforening. 128: 957-957.
- 2008. Patients with cardiac myxoma require surveillance for myxoma-related cerebral aneurysms. European Journal of Neurology. 15: E103-E109. doi: 10.1111/j.1468-1331.2008.02298.x
- 2008. Norsk nevrologi markerer seg internasjonalt. Axonet. 17: 18.
- 2008. Scientific activity within the European federation of neurological societies by Norwegian and British neurologists. Journal of Neurology, Neurosurgery and Psychiatry. 79: 346-346.
- 2008. A retrospective view on research in neuroscience in Norway. Acta Neurologica Scandinavica. 117: 3-5. doi: 10.1111/j.1600-0404.2008.01024.x
- 2008. Respiratory and cardiovascular dysfunctions are the main causes of death after traumatic spinal cord injury. European Journal of Neurology. 15: 18-18. doi: 10.1111/j.1468-1331.2008.02284.x
- 2008. Acetylcholine receptor antibodies in Norwegian myasthenia gravis patients. European Journal of Neurology. 15: 154-154. doi: 10.1111/j.1468-1331.2008.02285.x
- 2008. Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology. 201: 74-79. Published 2008-09-15. doi: 10.1016/j.jneuroim.2008.05.021
- 2008. Cytotoxic effects of myasthenia gravis sera on cardiomyocytes in vitro. Journal of Neuroimmunology. 203: 154-155.
- 2008. Report of the Task Force on pre-graduate education in Europe of the education committee of the European Federation of Neurological Societies Composition of the task force of the education committee on pre-graduate education. European Journal of Neurology. 15: e103-e109.
- 2008. Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis. Journal of Neuroimmunology. 201-202: 28-32.
- 2008. Left ventricular long-axis function in myasthenia gravis. Journal of Neurology. 255: 1777-1784. doi: 10.1007/s00415-008-0049-x
- 2008. Myasthenia Gravis and the Heart. Advances in Clinical Neuroscience & Rehabilitation. 8: 9-10.
- 2008. The risk of extrathymic malignancies in thymoma patients with and without myasthenia gravis. European Journal of Neurology. 15: 150-150. doi: 10.1111/j.1468-1331.2008.02285.x
- 2008. Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 195: 96-99. doi: 10.1016/j.jneuroim.2007.10.018
- 2007. Pregnancy, delivery and outcome for the child in maternal epilepsy. European Journal of Neurology. 14: 27-28.
- 2007. Polygenic disease associations in thymomatous myasthenia gravis. Archives of Neurology. 64: 1729-1733.
- 2007. Focal epileptiform activity described by a large computerised EEG database. Clinical Neurophysiology. 118: 1369-1376. doi: 10.1016/j.clinph.2007.02.027
- 2007. Focal epileptiform activity described by a large computerised EEG database. European Journal of Neurology. 14: 224-224.
- 2007. Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. European Journal of Neurology. 14: 1113-1117. doi: 10.1111/j.1468-1331.2007.01913.x
- 2007. Perinatal factors and later development of multiple sclerosis. Multiple Sclerosis. 13: S91-S92. doi: 10.1177/1352458507083605
- 2007. Smoking habits in pregnant MS women. European Journal of Neurology. 14: 278-278.
- 2007. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. European Journal of Neurology. 14: 60-65. doi: 10.1111/j.1468-1331.2006.01552.x
- 2007. Post-polio syndrome patients treated with intravenous immunoglobulin. A double blinded randomised controlled study. European Journal of Neurology. 14: 60-65.
- 2007. En diagnose for spesialister. Tidsskrift for Den norske legeforening. 127: 1530-1531.
- 2007. Grunnleggende om nervesystemets oppbygning og funksjon. Tidsskrift for Den norske legeforening. 127: 2852.
- 2007. Nevrorehabilitering som tverrfaglig oppgave. Tidsskrift for Den norske legeforening. 127: 329.
- 2007. Introduction: research in clinical neurology. Acta Neurologica Scandinavica. 115: 4-6. doi: 10.1111/j.1600-0404.2007.00839.x
- 2007. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. European Journal of Neurology. 14: 38-43. doi: 10.1111/j.1468-1331.2006.01538.x
- 2007. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. European Journal of Neurology. 14: 617-620. doi: 10.1111/j.1468-1331.2007.01785.x
- 2007. Pregnancy, delivery and perinatal outcome in female survivors of polio. Journal of the Neurological Sciences. 258: 27-32. doi: 10.1016/j.jns.2007.02.019
- 2006. Pregnancy, birth and perinatal outcome in women with former polio - Health aspects of polio sequel in fertile age. European Journal of Neurology. 13: 30-30.
- 2006. Pregnancy, delivery and birth outcome in mothers prior to debut of multiple sclerosis. European Journal of Neurology. 13: 28-29.
- 2006. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 113: 51-54. doi: 10.1111/j.1600-0404.2006.00616.x
- 2006. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 113: 51-54.
- 2006. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. European Journal of Neurology. 13: 913-922. doi: 10.1111/j.1468-1331.2006.01493.x
- 2006. EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. European Journal of Neurology. 13: 795-801. doi: 10.1111/j.1468-1331.2006.01385.x
- 2006. Svangerskap, fødsel og nevrologisk sykdom. Tidsskrift for Den norske legeforening. 126: 2506.
- 2006. Bergen International symposium in neuroimmunology 2006. Introduction. Acta Neurologica Scandinavica, Supplementum. 113: v-vi.
- 2006. Myasthenia gravis in pregnancy - Identifying risk factors, optimizing care. European Journal of Neurology. 13: 24-24.
- 2006. Artrogryposis multiplex congenita - a rare fetal condition caused by maternal myasthenia gravis. Acta Neurologica Scandinavica. 113: 26-27. doi: 10.1111/j.1600-0404.2006.00610.x
- 2006. Effects of myasthenia gravis patient sera on human myoblast cultures. Acta Neurologica Scandinavica. 113: 28-32. doi: Se sammendrag
- 2006. Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle and Nerve. 33: 93-103. doi: 10.1002/mus.20443
- 2006. Does myasthenia gravis provide protection against cancer? Acta Neurologica Scandinavica. 113: 33-36.
- 2006. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. Journal of Neurology, Neurosurgery and Psychiatry. 77: 203-207.
- 2006. Does myasthenia gravis provide protection against cancer? European Journal of Neurology. 13: 24-24.
- 2006. Myasthenia gravis: disease severity and prognosis. Acta Neurologica Scandinavica. 113: 24-25. doi: Se sammendrag
- 2006. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurologica Scandinavica. 113: 19-23. doi: Se sammendrag
- 2006. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 13: 691-699. doi: 10.1111/j.1468-1331.2006.01476.x
- 2005. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 65: 1961-1963.
- 2005. Fordypningsstillinger er en forskningsressurs. Tidsskrift for Den norske legeforening. 125: 2224-2225.
- 2005. Ny lærebok i nevroanatomi. Tidsskrift for Den norske legeforening. 125: 1037.
- 2005. Fordypningsstillinger er en forskningsressurs. Tidsskrift for Den norske legeforening. 125: 2224-2225.
- 2005. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 64: 459-462.
- 2005. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 64: 459-462.
- 2005. Seronegative myasthenia gravis; disease severity and prognosis. European Journal of Neurology. 12: 413-418.
- 2005. The role of complement in myasthenia gravis; serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 158: 191-194.
- 2004. EEG background activity described by a large computerized database. Clinical Neurophysiology. 115. 665-673.
- 2004. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. European Journal of Neurology. 11: 577-582.
- 2004. Intravenøst immunoglobulin ved postpolio syndrom. Tidsskrift for Den norske legeforening. 124: 2357-2358.
- 2004. Asymptomatic myasthenia gravis influences pregnancy and birth. European Journal of Neurology. 11: 559-562.
- 2004. MRI of the posterior tectorial and atlanto-occipital membranes in the late stage of whiplash injury. Neuroradiology. 46: 167-168.
- 2004. Cytoxic Effects of Myasthenia Gravis Patient Sera on Primary Human Skeletal Muscle Cell Cultures. Immunology. 131-134.
- 2004. Lifestyle and late effects after poliomyelitis. A risk factor study of two populations. Acta Neurologica Scandinavica. 109: 120-125.
- 2004. Tymektomi og muskelantistoffer ved myasthenia gravis. Tidsskrift for Den norske legeforening. 124: 629-631.
- 2004. Guidelines by the European Federation of Neurological Societies (EFNS) subcommittee for continuing medical education (CME). European Journal of Neurology. 11: 145-151.
- 2003. Myasthenia gravis in individuals over forty. Annals of the New York Academy of Sciences. 998: 424-431.
- 2003. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-456.
- 2003. Arvelige muskelsykdommer. Tidsskrift for Den norske legeforening. 123: 2588-2592.
- 2003. Post polio syndrome and total health status in a prospective health study. European Journal of Neurology. 10: 407-413.
- 2003. GM1-antibodies in post-polio syndrome and previous paralytic polio. Journal of Neuroimmunology. 139: 141-144.
- 2003. Research and specialty associations of the Medical Society. Tidsskrift for Den norske legeforening. 123: 1370-1371.
- 2003. Om helsetjenesten. Fordypningsstillinger for å fremme medisinsk forskning. Tidsskrift for Den norske legeforening. 123: 3415-3416.
- 2003. Forskning og Legeforeningens spesialforeninger. Tidsskrift for Den norske legeforening. 123: 1370-1371.
- 2003. Myesthenia gravis: Consequenses for pregnancy, delivery, and the newborn. Neurology. 61: 1362-1366.
- 2003. Myasthenia gravis. Consequences for pregnancy, delivery, and the newborn. Neurology. 61: 1362-1366.
- 2003. MRI of the tectorial and posterior atlanto-occipital membranes in the late stage of whiplash injury. Neuroradiology. 45: 585-591.
- 2003. MR analysis of the transverse ligament in the late stage of whiplash injury. Acta Radiologica. 44: 637-644.
- 2003. Long term outcome after poliomyelitis in different health and social conditions. Journal of Epidemiology and Community Health. 5: 368-372.
- 2003. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. European Journal of Neurology. 10: 701-706.
- 2003. Thymectomy in non-thymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European Neurology. 49: 210-217.
- 2003. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 998: 481-490.
- 2003. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle &Nerve. 27: 81-89.
- 2003. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 998: 350-353.
- 2002. Former poliomyelitis as a health and socioeconomic factor. A paired sibling study. Journal of Neurology. 249: 404-409.
- 2002. Education, occupation, and perception of health amongst previous polio patients compared to their siblings. European Journal of Neurology. 9: 233-241.
- 2002. Forskning og forbindelser. Tidsskrift for Den norske legeforening. 122: 1235.
- 2002. Nevrololgiforskning i Norge. Axonet. 11: 4-5.
- 2002. Hvordan virker nevrorehabiliteringen? Innsyn. 14-15.
Reports and theses
- 2003. Noen ord om klasehodepine. Pasientinformasjon utgitt av Norsk Nevrologisk Forening i 2003. Norsk Nevrologisk Forening.
Book sections
- 2013. Obstetrical outcome and complications of pregnancy. Kapittel, pages 128-135. In:
- 2013. Epilepsy in women. Wiley-Blackwell. 216 pages. ISBN: 978-0-470-67267-9.
- 2011. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces. 1, pages 5-10. In:
- 2011. European Handbook of Neurological Management. Volume 2. Wiley-Blackwell. 353 pages. ISBN: 978-1-4051-8534-9.
- 2011. Post-polio syndrome. Chapter 18, pages 311-319. In:
- 2011. European Handbook of Neurological Management Volume 1. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-5738-4.
- 2011. Introduction. Forord, pages 1-3. In:
- 2011. European Handbook of Neurological Management. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-8533-2.
- 2011. Cerebral vasculitis. 35, pages 485-490. In:
- 2011. European Handbook of Neurological Management. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-8533-2.
- 2011. Autoimmune neuromuscular transmission disorders. 19, pages 321-332. In:
- 2011. European Handbook of Neurological Management. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-8533-2.
- 2011. Use of antibody testing in nervous system disorders. 6, pages 75-80. In:
- 2011. European Handbook of Neurological Management. Wiley-Blackwell. 580 pages. ISBN: 978-1-4051-8533-2.
- 2009. Post-polio syndrome. Part 6, chapter 56, pages 212-214. In:
- 2009. International Neurology. Wiley-Blackwell. 728 pages. ISBN: 978-1-4051-5738-4.
- 2007. Nevromuskulære transmisjonssykdommer. kapittel, pages 245-250. In:
- 2007. Nevrologi og nevrokirurgi fra barn til voksen; undersøkelse-diagnose-behandling. 631 pages. ISBN: 9788241206283.
- 2007. Muskelsykdommer. Kapittel, pages 229-244. In:
- 2007. Nevrologi og nevrokirurgi fra barn til voksen; undersøkelse-diagnose-behandling. 631 pages. ISBN: 9788241206283.
- 2006. Guidance for development, refereeing and dissemination of guidelines. Chapter 3, pages 7-13. In:
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2006. Routine cerebrospinal fluid (CSF) analysis. Chapter 4, pages 14-27. In:
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2006. Post-polio syndrome. Chapter 21, pages 322-331. In:
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2006. Introduction: background to the book. Chapter 1, pages 1-2. In:
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2006. Autoimmune neuromuscular conduction disorders. Chapter 22, pages 332-343. In:
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2006. Use of anti-nerve antibodies. Chapter 9, pages 87-93. In:
- 2006. European Handbook of Neurological Management. Blackwell Publishing. 640 pages. ISBN: 978-1-4051-3050-9.
- 2003. Muskelsykdommer. Muskelsykdommer (2003), pages 215-230. In:
- 2003. Nevrologi og nevrokirurgi (3.utg) fra barn til voksen;undersøkelse, diagnose, behandling. 671 pages.
- 2003. Myasthenia gravis og andre nevromuskulære transmisjonssykdommer. Kapittel, pages 231-326. In:
- 2003. Nevrologi og Nevrokirurgi. Fra barn til voksen. Undersøkelse, diagnose, behandling. [3. rev. utg.]. Forlaget Vett & Viten. 671 pages. ISBN: 82-412-0556-2.
- 2003. Muskelsykdommer. Kapittel, pages 215-230. In:
- 2003. Nevrologi og Nevrokirurgi. Fra barn til voksen. Undersøkelse, diagnose, behandling. [3. rev. utg.]. Forlaget Vett & Viten. 671 pages. ISBN: 82-412-0556-2.
- 2002. Paraneoplastic neurological syndromes. 95-97. In:
- 2002. Temel ve Klinik Nöroimmünoloji.
- 2002. Dystrophia myotonica. 1-3. In:
- 2002. Libra nettverk. MANGLER.
- 2002. Research in neurorehabilitation. 545-552. In:
- 2002. Neurological Rehabilitation.
- 2002. The neuromuscular junction as a target for paraneoplastic disease. 1-10. In:
- 2002. Proc 6th EFNS Congress.
More information in national current research information system (CRIStin)
Fields of competence